Integrum implants first U.S. patient with e-OPRA under FDA IDE

Integrum said its e-OPRA system was implanted in the first U.S. patient under an FDA IDE at Northwestern Memorial Hospital. A NIH-funded study plans 8 patients and is expected to conclude in 2030.